About
Diabetes & Obesity Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalMidwest
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
810
By Phase
PHASE2: 6PHASE2/PHASE3: 1
By Status
COMPLETED: 6ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06238778Lead Sponsor
Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec
PHASE2Active, not recruiting
227 participants
Started: Jan 23, 2024 · Completed: Dec 31, 2025
NCT03938740Lead Sponsor
Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec
PHASE2Completed
61 participants
Started: Mar 18, 2019 · Completed: Mar 18, 2020
NCT03156361Lead Sponsor
21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus
PHASE2Completed
24 participants
Started: May 18, 2017 · Completed: Mar 15, 2018
NCT03096392Lead Sponsor
Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control
PHASE2Completed
46 participants
Started: Apr 18, 2017 · Completed: Mar 18, 2018
NCT02794155Lead Sponsor
Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)
PHASE2Completed
157 participants
Started: Jun 30, 2016 · Completed: Jun 15, 2018
Locations (1)
Headquarters
Cleveland, OH, United States
Map
Loading map...